Concepedia

Publication | Open Access

P53 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma

DOIFull Paper Access

10

Citations

18

References

2021

Year

Yohei Sekino, Kenshiro Takemoto, Daiki Murata, Takashi Babasaki, Kohei Kobatake, Hiroyuki Kitano, Kenichiro Ikeda, Keisuke Goto, Shogo Inoue, Tetsutaro Hayashi,
Anticancer Research

Abstract

p53 may be involved in sunitinib resistance and represent a valuable marker for sunitinib treatment in mRCC.

References

YearCitations

Page 1